<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="article-commentary">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">CPJ</journal-id>
<journal-id journal-id-type="hwp">spcpj</journal-id>
<journal-id journal-id-type="nlm-ta">Clin Pediatr (Phila)</journal-id>
<journal-title>Clinical Pediatrics</journal-title>
<issn pub-type="ppub">0009-9228</issn>
<issn pub-type="epub">1938-2707</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0009922811419496</article-id>
<article-id pub-id-type="publisher-id">10.1177_0009922811419496</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Commentary</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Approach to Neonatal Seizures</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Sivaswamy</surname><given-names>Lalitha</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0009922811419496">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-0009922811419496"><label>1</label>Children’s Hospital of Michigan, Detroit, MI, USA</aff>
<author-notes>
<corresp id="corresp1-0009922811419496">Lalitha Sivaswamy, Department of Neurology, Children’s Hospital of Michigan, 3901 Beaubien, Detroit, MI 48201, USA Email: <email>lsivaswamy@med.wayne.edu</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>5</month>
<year>2012</year>
</pub-date>
<volume>51</volume>
<issue>5</issue>
<fpage>415</fpage>
<lpage>425</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>Neonatal seizures can be difficult to recognize given the variation in their presentation. Hence, diagnosis and appropriate treatment may be delayed. Morphology of seizures in this age group is discussed, followed by common etiological entities. Special emphasis is laid on treatable disease states such as vitamin responsive seizure disorders and benign conditions that may not warrant aggressive treatment. Conditions that may have devastating neurological consequences are discussed in some detail so that the treating pediatrician can provide realistic information to the parents of such newborns. Imaging and laboratory workup is outlined, followed by guidelines for ordering and interpreting an electroencephalogram in this age group. Finally, treatment options in the form of antiepileptics are discussed with mention of new avenues for diagnosis and treatment that may become commonly employed in the future.</p>
</abstract>
<kwd-group>
<kwd>seizures</kwd>
<kwd>neonatal</kwd>
<kwd>EEG</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Recognizing seizures in the newborn period can be challenging as “events” may be subtle and neonates often exhibit mannerisms that can be confused with seizures. Furthermore, there is a large and potentially daunting list of etiologies that may test the diagnostic skills of even the more experienced clinician. In this review, I will summarize historical aspects, physical findings, and investigations that can point to recognition and diagnosis of neonatal seizures in a timely manner. As in most clinical situations, while early recognition can help with initiation of treatment, unearthing the <italic>underlying etiology</italic> is crucial for prognostication.</p>
<p>The incidence of neonatal seizures in the general population is reported to be 2.5 to 3.5 per 1000 in full term newborns, more than at any other period in childhood.<sup><xref ref-type="bibr" rid="bibr1-0009922811419496">1</xref>,<xref ref-type="bibr" rid="bibr2-0009922811419496">2</xref></sup> In studies of babies hospitalized in intensive care units, it can be as high as 2.3%.<sup><xref ref-type="bibr" rid="bibr3-0009922811419496">3</xref></sup> Interestingly, in utero seizures have also been reported and even captured by ultrasonography.<sup><xref ref-type="bibr" rid="bibr4-0009922811419496">4</xref></sup></p>
<sec id="section1-0009922811419496">
<title>What Do Seizures in Neonates Look Like?</title>
<p>Because of the unique nature of neonatal brain anatomy, connections, and somewhat paradoxical nature of neurotransmitters, seizures in this age group vary in semiology from those in older children. Volpe<sup><xref ref-type="bibr" rid="bibr5-0009922811419496">5</xref></sup> has proposed the following classification that is widely accepted:</p>
<list id="list1-0009922811419496" list-type="order">
<list-item><p><italic>Clonic</italic>. Rhythmic movements involving the face, arms, legs, or trunk, either on one side of the body (focal) or multifocal involving multiple areas of the body but shifting rapidly from one site to another. These types are most easily identified as a seizure by clinical observation.</p></list-item>
<list-item><p><italic>Tonic</italic>. Usually generalized, involving both upper and lower extremities in extension or tonic flexion of the arms with extension of the legs (decorticate posturing).</p></list-item>
<list-item><p><italic>Myoclonic</italic>. Resemble clonic movements but they are “quicker” and hence the infant appears more “jerky.”</p></list-item>
<list-item><p><italic>Subtle</italic>. These types are more common in premature infants. They can be horizontal eye deviation or sustained eye opening, chewing movements of the mouth, or apneic spells. The latter can be most difficult to identify as apnea of prematurity, in general, is more likely to be nonepileptic. A useful caveat is that most newborns who have apnea as a seizure manifestation do not have accompanying bradycardia.<sup><xref ref-type="bibr" rid="bibr6-0009922811419496">6</xref></sup></p></list-item>
</list>
</sec>
<sec id="section2-0009922811419496">
<title>History</title>
<p>Undoubtedly, a detailed antenatal history is of great benefit. Relevant aspects of the mother’s history that may be helpful include previous miscarriages, gestational diabetes, infections including sexually transmitted diseases, use of prescription and illegal drugs, clotting or bleeding tendencies, and family history of epilepsy in the mother (especially in infancy) or other family members. A history of consanguinity may point to certain inborn errors of metabolism. Mothers of babies with nonketotic hyperglycinemia have noted hiccups of their babies in utero.</p>
<p>Birth history is of interest from the point of view of ascertaining whether the baby may have suffered birth asphyxia. Nature of delivery is relevant as babies born by vaginal delivery are more likely to have intracranial hemorrhage.<sup><xref ref-type="bibr" rid="bibr7-0009922811419496">7</xref></sup></p>
</sec>
<sec id="section3-0009922811419496">
<title>Physical Examination</title>
<p>Certain aspects of the physical examination may serve as clues to diagnosis of the underlying etiology. Of prime importance is measurement of head circumference as microcephaly can be indicative of underlying brain malformation. Birthmarks, somatic anomalies, facial dysmorphology, and an abnormal neurological examination may direct the physician to certain underlying causes. See <xref ref-type="table" rid="table1-0009922811419496">Table 1</xref> for common recognizable associations.</p>
<table-wrap id="table1-0009922811419496" position="float">
<label>Table 1.</label>
<caption>
<p>Physical Examination Correlates in Neonatal Seizures</p>
</caption>
<graphic alternate-form-of="table1-0009922811419496" xlink:href="10.1177_0009922811419496-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th align="left">Physical Exam Finding</th>
<th align="center">Neurological Correlate</th>
</tr>
</thead>
<tbody>
<tr>
<td>Macrocephalay</td>
<td>Hydrocephalus</td>
</tr>
<tr>
<td/>
<td>Hemimegalencephaly</td>
</tr>
<tr>
<td>Microcephaly</td>
<td>Brain malformation (eg, lissencephaly)</td>
</tr>
<tr>
<td/>
<td>Congenital CNS infections</td>
</tr>
<tr>
<td>Skin findings</td>
<td/>
</tr>
<tr>
<td> Orange-yellow plaques on the scalp (nevus sebaceous of Jadahsson)</td>
<td/>
</tr>
<tr>
<td> Lack of hair and skin in a localized area (cutis aplasi)</td>
<td>Underlying brain dysplasia</td>
</tr>
<tr>
<td> Port wine stain on the forehead and upper lid</td>
<td/>
</tr>
<tr>
<td> Blisters in a dermatomal pattern (incontinentia pigmenti)</td>
<td/>
</tr>
<tr>
<td> Blisters on the scalp (herpes simplex)</td>
<td/>
</tr>
<tr>
<td> Nevus in a dermatomal pattern</td>
<td/>
</tr>
<tr>
<td> Ash leaf macule</td>
<td>Tuberous sclerosis</td>
</tr>
<tr>
<td>Fundus</td>
<td/>
</tr>
<tr>
<td> Hypoplastic optic nerves</td>
<td>Brain dysplasia (eg, septo optic dysplasia)</td>
</tr>
<tr>
<td> Coloboma of the retina</td>
<td>Agenesis of the corpus callosum</td>
</tr>
<tr>
<td> Chorioretinitis</td>
<td>Congenital CNS infections</td>
</tr>
<tr>
<td> Retinal pigmentation</td>
<td>Neuronal ceroid lipofuscinosis</td>
</tr>
<tr>
<td>Facial features</td>
<td/>
</tr>
<tr>
<td> Closely set eyes, cleft lip, cleft palate</td>
<td>Brain dysplasia (eg, holoprosencephaly)</td>
</tr>
<tr>
<td> Epicanthic folds, “jowly” appearance</td>
<td>Zellweger syndrome with brain malformation</td>
</tr>
<tr>
<td> Unusual body odor</td>
<td>Metabolic defect (eg, isovaleric academia)</td>
</tr>
<tr>
<td> Vomiting after feeds, lethargy after the first week of life</td>
<td>Urea cycle defects</td>
</tr>
<tr>
<td>Port wine stain and varicose veins on limbs (Klippel–Trenaunay–Weber syndrome)</td>
<td>Brain anomalies</td>
</tr>
<tr>
<td>Lethargy, poorly responsive neonate, hypotonia, poor suck</td>
<td>Neonatal encephalopathy (eg, HIE, stroke, inborn metabolic defect)</td>
</tr>
<tr>
<td>Bradycardia, unequal pupils</td>
<td>Subdural hemorrhage</td>
</tr>
<tr>
<td>Jittery, high-pitched cry, difficult to console</td>
<td>Passive drug addiction</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0009922811419496">
<p>Abbreviation: CNS, central nervous system; HIE, hypoxic-ischemic encephalopathy.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section4-0009922811419496">
<title>Imaging and Laboratory Workup</title>
<p>Magnetic resonance imaging (MRI) is preferable to computed tomography (CT) or ultrasound as it has greater sensitivity in identifying brain malformations, intracranial hemorrhage, and ischemic damage. Additional sequences such as magnetic resonance angiography and magnetic resonance venography may be required when stroke is suspected, while techniques such as diffusion weighted imaging (DWI) are helpful in detecting early hypoxic injury.<sup><xref ref-type="bibr" rid="bibr8-0009922811419496">8</xref></sup> <xref ref-type="fig" rid="fig1-0009922811419496">Figure 1A</xref> and <xref ref-type="fig" rid="fig1-0009922811419496">B</xref> depicts DWI and corresponding apparent diffusion coefficient images showing hypoxic damage to bilateral parietal and occipital white matter in a neonate.</p>
<fig id="fig1-0009922811419496" position="float">
<label>Figure 1.</label>
<caption>
<p>Axial 1.5-T MRI of a newborn with hypoxic ischemic encephalopathy. Bright signal on DWI (A) and dark signal on ADC maps (B) are early changes that are clearly demonstrated using these MRI sequences</p>
</caption>
<graphic xlink:href="10.1177_0009922811419496-fig1.tif"/>
</fig>
<p>Abnormalities in the white matter would be typical of certain metabolic/degenerative conditions such as Alexander disease, Krabbe disease, disorders of mitochondrial energy metabolism, and Pelizaeus–Merzbacher disease. Similarly, dysgenesis of the corpus callosum, which may be a marker of other congenital brain anomalies, may also be associated with certain metabolic defects such as nonketotic hyperglycinemia and pyruvate dehydrogenase deficiency.<sup><xref ref-type="bibr" rid="bibr9-0009922811419496">9</xref></sup> Migrational anomalies such as brain heterotopias may well be the cause of seizures but can also be markers for metabolic defects involving mitochondrial function.</p>
<p>Laboratory tests of value include spinal fluid cultures and analysis with polymerase chain reaction for herpes simplex DNA, serum electrolytes, serum glucose, and cultures of blood and urine. When an underlying metabolic defect is likely, testing spinal fluid for glycine (nonketotic hyperglycinemia), lactic acid (mitochondrial disorders), and neurotransmitters (HIAA and HVA) is worthwhile. Elevated ammonia level may indicate a defect of the urea cycle or organic acid metabolism. Serum lactic acid can be elevated in disorders of organic acid metabolism, for example, propionic acidemia, methylmalonic acidemia, and fatty acid oxidation defects.</p>
</sec>
<sec id="section5-0009922811419496">
<title>Epilepsy Syndromes in a Well-Appearing Infant With a Negative Workup</title>
<p>It is not uncommon to have a normal examination and well-appearing baby on whom one is consulted for recurrent seizures. In these instances, an early “epilepsy syndrome” may be under consideration. These include the following:</p>
<list id="list2-0009922811419496" list-type="order">
<list-item><p><italic>Benign familial neonatal convulsions</italic>. These infants have a family history of neonatal seizures, a “reassuring” physical exam, negative workup for other potential etiologies, and early (within the first week) onset of events. The seizure type most commonly associated is tonic extension followed by clonic movements.<sup><xref ref-type="bibr" rid="bibr10-0009922811419496">10</xref></sup> Linkage analysis has noted association with chromosomes 20q and 8q with the implicated genes coding for K channels expressed in the brain.<sup><xref ref-type="bibr" rid="bibr11-0009922811419496">11</xref>,<xref ref-type="bibr" rid="bibr12-0009922811419496">12</xref></sup></p></list-item>
<list-item><p><italic>Benign nonfamilial (idiopathic) neonatal seizures</italic>. These were first described by Dehen et al in 1977 and they coined the term <italic>fifth-day fits</italic>. These events are mostly clonic but may have apnea as an associated manifestation. Seizures may be recurrent and even present as status epilepticus. These infants must also have a negative workup for other underlying seizure etiologies and a negative family history.<sup><xref ref-type="bibr" rid="bibr13-0009922811419496">13</xref></sup></p></list-item>
</list>
</sec>
<sec id="section6-0009922811419496">
<title>Epilepsy Syndromes in a Neonate With Underlying Etiology</title>
<p>Two seizure syndromes that may occur in the neonate will be discussed in some detail due to the devastating impact they may have on neurodevelopmental outcomes.</p>
<list id="list3-0009922811419496" list-type="order">
<list-item><p>Otahara syndrome (early infantile epileptic encephalopathy) was first described by Otahara and colleagues in 1976.<sup><xref ref-type="bibr" rid="bibr14-0009922811419496">14</xref></sup> The infant has multiple tonic seizures over the course of the day and is poorly responsive to medications. More than three fourths of such children develop infantile spasms in later infancy. Oftentimes, an underlying brain malformation is noted on imaging.</p></list-item>
<list-item><p>Early myoclonic epileptic encephalopathy presents with fragmentary myoclonus and partial seizures and is oftentimes the manifestation of an underlying metabolic defect.<sup><xref ref-type="bibr" rid="bibr15-0009922811419496">15</xref></sup></p></list-item>
</list>
<p>Both these epilepsy syndromes have poor prognosis for survival and neurological outcome. These epilepsy syndromes have a burst suppression pattern on electroencephalogram (EEG) that may alert the pediatrician to the serious nature of the baby’s neurological status.</p>
</sec>
<sec id="section7-0009922811419496">
<title>Etiology of Neonatal Seizures</title>
<p>Most neonates, 75% to 90%, with seizures have an underlying etiology.<sup><xref ref-type="bibr" rid="bibr16-0009922811419496">16</xref></sup> Therefore, it is incumbent on the clinician to not only treat the events if recurrent but, more important, also unearth the underlying cause. A brief overview of the more common causes, in order of frequency, is outlined below.</p>
<sec id="section8-0009922811419496">
<title>Hypoxic-Ischemic Encephalopathy (HIE)</title>
<p>The majority of neonatal seizures are attributed to HIE, with some estimates placing it more than 50%.<sup><xref ref-type="bibr" rid="bibr5-0009922811419496">5</xref>,<xref ref-type="bibr" rid="bibr17-0009922811419496">17</xref></sup> Seizures in HIE occur between 4 and 24 hours after birth.<sup><xref ref-type="bibr" rid="bibr18-0009922811419496">18</xref></sup> A preceding history of neonatal encephalopathy is essential before one can consider HIE as a potential etiology. Neonatal encephalopathy is defined on the basis of a constellation of clinical symptoms including altered sensorium, tone, feeding, and/or seizures. It is believed that most events leading to neonatal encephalopathy occur in the antenatal period, with intrapartum events accounting for a minority.<sup><xref ref-type="bibr" rid="bibr19-0009922811419496">19</xref></sup> Hence, it is clear that a low APGAR alone or intrapartum events in isolation cannot be used to justifiably classify events as being related to HIE.</p>
</sec>
<sec id="section9-0009922811419496">
<title>Intracranial Hemorrhage</title>
<sec id="section10-0009922811419496">
<title>Subarachnoid hemorrhage</title>
<p>Primary subarachnoid hemorrhage can be relatively innocuous and the infant can appear well. It is believed to be the result of rupture of leptomeningeal vessels.<sup><xref ref-type="bibr" rid="bibr20-0009922811419496">20</xref></sup> Ultrasound may fail to delineate the blood and hence early CT/MRI is crucial to arrive at a diagnosis. Most infants with subarachnoid hemorrhage do well in terms of neurodevelopmental outcome with the rare complication of hydrocephalus.</p>
</sec>
<sec id="section11-0009922811419496">
<title>Subdural hemorrhage</title>
<p>This is the least common of the subtypes of neonatal intracranial hemorrhage. It may be the result of laceration of the tentorium or falx or rupture of bridging superficial cerebral veins.<sup><xref ref-type="bibr" rid="bibr5-0009922811419496">5</xref></sup> It is predominantly reported in full term infants and predisposing factors can include a large for gestational age infant, precipitous/prolonged delivery, a difficult extraction with vacuum/forceps, and unusual deforming forces on an after coming head in breech presentations. <xref ref-type="fig" rid="fig2-0009922811419496">Figure 2</xref> depicts a left parietal subdural hematoma shown on axial MRI.</p>
<fig id="fig2-0009922811419496" position="float">
<label>Figure 2.</label>
<caption>
<p>Axial 1.5-T MRI depicting left subdural hematoma on the parietal convexity of a newborn born via vaginal delivery</p>
</caption>
<graphic xlink:href="10.1177_0009922811419496-fig2.tif"/>
</fig>
</sec>
<sec id="section12-0009922811419496">
<title>Intraventricular hemorrhage</title>
<p>This type occurs almost exclusively in preterm babies. The incidence in infants of 500 to 800 g is estimated to be 45% while the overall rate is in the 20% to 25% range.<sup><xref ref-type="bibr" rid="bibr21-0009922811419496">21</xref>,<xref ref-type="bibr" rid="bibr22-0009922811419496">22</xref></sup> In addition to seizures, babies with germinal matrix-intraventricular hemorrhage often have other accompanying symptoms such as apnea, hypotonia, and altered level of consciousness. However, it is not uncommon to have no clinical manifestations at all in the newborn period (see <xref ref-type="fig" rid="fig3-0009922811419496">Figure 3</xref>).</p>
<fig id="fig3-0009922811419496" position="float">
<label>Figure 3.</label>
<caption>
<p>Preterm neonate with extensive intraventricular hemorrhage involving frontal and occipital horns of the lateral ventricles. T2*GRE images help in clear delineation of blood (1.5-T MRI)</p>
</caption>
<graphic xlink:href="10.1177_0009922811419496-fig3.tif"/>
</fig>
</sec>
</sec>
<sec id="section13-0009922811419496">
<title>Infection</title>
<p>Bacterial meningitis is by far the most common cause of seizures in this category, especially <italic>Escherichia coli</italic> and Group B β hemolytic <italic>Streptococcus</italic>. Septicemia without meningitis may also lead to seizures.</p>
<p>Of the nonbacterial infections herpes simplex encephalitis caused by HSV-2 accounts for the majority. The reported prevalence in the United States is 1 in 3000 for full term live infants.<sup><xref ref-type="bibr" rid="bibr23-0009922811419496">23</xref></sup> Seizures usually begin after the first few weeks of life. If the mother has a primary genital infection, there is a 30% to 50% chance that the child will develop a neonatal infection. The newborn is affected by contact with active maternal genital herpes. More than half of neonatal herpes survivors suffer neurologic sequelae; hence, early detection is of vital importance.<sup><xref ref-type="bibr" rid="bibr24-0009922811419496">24</xref></sup></p>
</sec>
<sec id="section14-0009922811419496">
<title>Brain Malformations</title>
<p>Severe brain malformations tend to cause early seizures. These include holoprosencephaly (partial or complete failure of segmentation of the forebrain), schizencephaly (clefts in the brain parenchyma), neuronal heterotopias (islands of displaced neurons within the white matter), and hemimegalencephaly (see <xref ref-type="fig" rid="fig4-0009922811419496">Figures 4</xref> and <xref ref-type="fig" rid="fig5-0009922811419496">5</xref>). Aberrations of brain development that are most likely to cause seizures are those that cause <italic>cortical</italic> dysgenesis.</p>
<fig id="fig4-0009922811419496" position="float">
<label>Figure 4.</label>
<caption>
<p>Lobar holoprosencephaly depicted in axial FLAIR sequences with fusion of the frontal lobes anteriorly and single ventricle (1.5-T MRI)</p>
</caption>
<graphic xlink:href="10.1177_0009922811419496-fig4.tif"/>
</fig>
<fig id="fig5-0009922811419496" position="float">
<label>Figure 5.</label>
<caption>
<p>Open lip schizencephaly on axial FLAIR images in a neonate with intractable epilepsy. Note the large cleft extending from the surface of the brain to the ventricles (1.5-T MRI)</p>
</caption>
<graphic xlink:href="10.1177_0009922811419496-fig5.tif"/>
</fig>
</sec>
<sec id="section15-0009922811419496">
<title>Metabolic Disturbances</title>
<p>Transient disturbances in glucose metabolism are particularly common in infants of diabetic mothers and premature babies. A serum value of less than 20 mg/dL in the premature infant and 40 mg/dL in the term is considered low. However, symptomatic hypoglycemia may be reflective of an underlying condition such as sepsis, asphyxia, aminoacidurias (eg, maple syrup urine disease), disorders of carbohydrate metabolism (eg, galactosemia), or a fatty acid oxidation defect. Other symptoms in these babies include irritability, jitteriness, and poor feeding.</p>
<p>Early onset hypocalcemia may also precipitate seizures, and potential etiologies for the former include asphyxia, transient neonatal hypoparathyroidism, and low birth weight. Hypocalcemia that appears later may be indicative of the DiGeorge syndrome.<sup><xref ref-type="bibr" rid="bibr25-0009922811419496">25</xref></sup></p>
<p>Urea cycle disturbances can cause seizures due to accumulation of ammonia. These usually present after the first few weeks of life as there is progressive accumulation of protein. Of these conditions ornithine transcarbamyl deficiency is X-linked whereas the rest are autosomal recessive. In addition to urea cycle disturbances, other causes of neonatal hyperammonemia including hepatic failure and disorders of amino acid metabolism must be kept in mind.</p>
<p>Specific mention must be made of a disorder of glucose transport (glucose transporter deficiency described by De Vivo et al in 1991) where early recognition is of great importance as these children respond well to institution of the ketogenic diet.<sup><xref ref-type="bibr" rid="bibr26-0009922811419496">26</xref></sup> It is caused by a defect in Glut1, which is responsible for diffusion of glucose across the blood–brain barrier and babies have disproportionately low values of glucose in spinal fluid.</p>
<sec id="section16-0009922811419496">
<title>Vitamin responsive seizure disorders</title>
<p>Pyridoxine dependency warrants special attention as it manifests as an early onset seizure disorder, refractory to traditional antiepileptic medications; is inherited in an autosomal recessive manner; and found to be associated with a mutation in the <italic>ALDH7A1</italic> gene.<sup><xref ref-type="bibr" rid="bibr27-0009922811419496">27</xref></sup> When inadequately treated these babies can progress to status epilepticus.</p>
<p>Folinic acid responsive seizures, first described in 1995, represent another subgroup, which responds completely to folinic acid supplementation.<sup><xref ref-type="bibr" rid="bibr28-0009922811419496">28</xref></sup></p>
<p>Finally, a mutation in the <italic>PNPO</italic> gene is responsible for pyridoxal phosphate-dependent seizures.<sup><xref ref-type="bibr" rid="bibr29-0009922811419496">29</xref></sup> These are not only responsive to anticonvulsant medications but also to pyridoxine. Supplementation with pyridoxal phosphate is the treatment of choice.</p>
</sec>
</sec>
<sec id="section17-0009922811419496">
<title>Perinatal Stroke</title>
<p>With an incidence of 1 in 2300 to 1 in 5000 in term neonates, the occurrence of stroke is highest in the neonatal period compared with any other time frame in childhood.<sup><xref ref-type="bibr" rid="bibr30-0009922811419496">30</xref></sup> The incidence is even higher in preterm infants with a gestational age of less than 34 weeks. While focal seizures draw attention to the underlying lesion about 75% of the time in term babies, this is the presenting feature in only a quarter of the preterm population.<sup><xref ref-type="bibr" rid="bibr31-0009922811419496">31</xref></sup></p>
<p>Seizures have also been identified as the most common presentation of perinatal venous sinus thrombosis.<sup><xref ref-type="bibr" rid="bibr32-0009922811419496">32</xref></sup> Other clinical features may be apparent including depressed sensorium, apnea, and irritability.</p>
</sec>
<sec id="section18-0009922811419496">
<title>Drug Withdrawal</title>
<p>Seizures occur in babies passively addicted to drugs due to in utero exposure. They are uncommon with heroin addiction but occur with slightly greater frequency in babies exposed to methadone, selective serotonin reuptake inhibitors, barbiturates, and alcohol.<sup><xref ref-type="bibr" rid="bibr33-0009922811419496">33</xref>,<xref ref-type="bibr" rid="bibr34-0009922811419496">34</xref></sup> Babies with withdrawal syndrome, irrespective of the agent, have similar clinical features consisting of jitteriness, shrill cry, poor feeding, and hypertonicity.</p>
</sec>
<sec id="section19-0009922811419496">
<title>Neurocutaneous Syndromes</title>
<p>In rare instances, neonatal epilepsy can be the presenting feature of tuberous sclerosis or Sturge–Weber syndrome, though in most cases onset of seizures is later in infancy.<sup><xref ref-type="bibr" rid="bibr35-0009922811419496">35</xref>,<xref ref-type="bibr" rid="bibr36-0009922811419496">36</xref></sup></p>
</sec>
</sec>
<sec id="section20-0009922811419496">
<title>Seizures in Preterm Infants</title>
<p>With the remarkable progress in perinatal medicine, physicians are increasingly faced with the challenge of dealing with seizures in this subgroup. The reported prevalence varies widely from 2.3% to 22.7%.<sup><xref ref-type="bibr" rid="bibr37-0009922811419496">37</xref>,<xref ref-type="bibr" rid="bibr38-0009922811419496">38</xref></sup> The latency to seizure onset in this age group tends to be more than in term babies, which may be attributed to brain immaturity. Mortality of more than 30% was noted in a recent study of premature babies with gestational age of less than 32 weeks with seizures, which is higher than a similar cohort without seizures. Eighty percent of babies in this study (which also included preterm babies of less than 30 weeks gestational age) developed neurological sequelae.<sup><xref ref-type="bibr" rid="bibr39-0009922811419496">39</xref></sup> Risk factors for seizures in this age group include a lower gestational age, hypoxic ischemic encephalopathy, respiratory distress syndrome, intraventricular hemorrhage, necrotozing enterocolitis, and patent ductus arteriosus.</p>
</sec>
<sec id="section21-0009922811419496">
<title>Role of EEG in Neonatal Seizures: Precautions and Pitfalls</title>
<p>The EEG can be a valuable asset in confirming that a given event is likely to be a seizure. Certain caveats must however be kept in mind. First, electrographic seizures may occur without clinical accompaniment. This appears to be common in infants receiving phenobarbital.<sup><xref ref-type="bibr" rid="bibr40-0009922811419496">40</xref></sup> In contrast, a neonate may demonstrate phenomena traditionally regarded as clinical seizures with no EEG correlate.<sup><xref ref-type="bibr" rid="bibr41-0009922811419496">41</xref></sup> This type of “electroclinical dissociation” is fairly common and peculiar to the newborn period. Most subtle and generalized tonic seizures are usually not accompanied by electrographic discharges, whereas clonic seizures are typically associated with recognizable electrographic spikes.<sup><xref ref-type="bibr" rid="bibr42-0009922811419496">42</xref></sup></p>
<p>Second, focal epileptiform activity does not imply focal pathology as it does in older age groups. Hence, a condition such as hypoglycemia, causing neonatal seizures, may demonstrate epileptiform discharges confined to 1 hemisphere. Finally, interictal spikes, though present more often in newborns with seizures than those without, can be hard to differentiate from normal EEG morphology at this age. Undue reliance on this finding may be imprudent.</p>
<p>In summary, neonatal EEG is most useful when the ictal event itself is captured and there is good clinical EEG correlate. Long-term recordings, using technology such as amplitude-integrated EEG, are useful in clinical practice with short (“routine”) EEGs being of limited benefit.<sup><xref ref-type="bibr" rid="bibr43-0009922811419496">43</xref></sup> Last, both technician and physician must be familiar with the newborn EEG and be aware of the baby’s clinical state and medications being used. <xref ref-type="fig" rid="fig6-0009922811419496">Figure 6A</xref> and <xref ref-type="fig" rid="fig6-0009922811419496">B</xref> depicts the EEG of a neonate, born at 31 weeks of gestational age, with seizure discharges commencing in the left hemisphere and progressing to an electrographic event with no clinically detectable seizure.</p>
<fig id="fig6-0009922811419496" position="float">
<label>Figure 6.</label>
<caption>
<p>(A) Neonatal EEG with arrows pointing to the sharply contoured waves arising from the left temporal region prior to onset of clinical seizures. (B) EEG recording 10 seconds later showing recording during electrographic seizure. This neonate had no clinical events during the recording</p>
</caption>
<graphic xlink:href="10.1177_0009922811419496-fig6.tif"/>
</fig>
</sec>
<sec id="section22-0009922811419496">
<title>Consequences of Neonatal Seizures</title>
<p>Term infants who experience seizures are more likely to have a good outcome compared with preterm babies.<sup><xref ref-type="bibr" rid="bibr44-0009922811419496">44</xref></sup> Other factors associated with adverse outcomes include early onset seizures, especially those on the first day of life; “subtle” seizure semiology; and an abnormal EEG background. The fact that most seizures arising in the first 24 hours are the result of global brain damage, such as birth asphyxia, may account for this apparent causation.<sup><xref ref-type="bibr" rid="bibr45-0009922811419496">45</xref></sup> In infants with HIE, seizure severity appears to add an extra burden to the developmental outcome over and above that imposed by the underlying etiology. It has been postulated that neonatal seizures worsen outcome due to the increased demands they impose on brain energy supply as reflected in magnetic resonance spectroscopy studies.<sup><xref ref-type="bibr" rid="bibr46-0009922811419496">46</xref></sup> On the whole, recent studies have placed the risk of developing an adverse neurological outcome after neonatal seizures between 28% and 46%.<sup><xref ref-type="bibr" rid="bibr47-0009922811419496">47</xref>,<xref ref-type="bibr" rid="bibr48-0009922811419496">48</xref></sup> To a large extent the outcome is dependent on the underlying cause. However, prognosis of each of the etiological subtypes must be taken into consideration prior to counseling families regarding likely outcomes.</p>
</sec>
<sec id="section23-0009922811419496">
<title>Differential Diagnosis</title>
<p>Jitteriness (recurrent tremor) is fairly common in newborns.<sup><xref ref-type="bibr" rid="bibr49-0009922811419496">49</xref></sup> It is characterized by tremulousness of all limbs or may involve 1 limb alone. Nonetheless, as noted in previous sections, it may have a pathological basis and is fairly prominent in neonates with HIE, hypoglycemia, hypocalcemia, and drug withdrawal. Jitteriness can be differentiated from seizures on the basis of response to restraint and lack of associated features such as tachycardia or apnea.</p>
<p>Hyperekplexia is an autosomal dominant condition, with a mild form, wherein the newborn exhibits exaggerated startle in the awake state, and a more severe form, with generalized stiffness with no clear cut precipitating stimulus. The genetic defect is linked to chromosome 5q.</p>
<p>Benign neonatal sleep myoclonus manifests as limb movements that occur during slow wave sleep. They are most commonly observed in the arms and can occur in rapid succession causing concern in the caregivers.<sup><xref ref-type="bibr" rid="bibr50-0009922811419496">50</xref></sup></p>
</sec>
<sec id="section24-0009922811419496">
<title>Treatment</title>
<p>The consensus of opinion indicates that <italic>recurrent seizures</italic> in the neonatal period should be treated in view of the demands such events place on the metabolic needs of the developing brain and potential adverse effects on respiratory function and circulatory hemodynamics. The more knotty issue that presents itself to the clinician is whether treatment of <italic>clinical</italic> or <italic>electrographic</italic> seizures should be the goal of treatment. Effective control of the former is more easily achieved, though freedom from electrographic seizures is the goal in most instances.</p>
<p>The duration of treatment depends on the underlying condition. No clear cut guidelines have been set forth by the Child Neurology Society or the American Academy of Pediatrics. Volpe suggests weaning of medications after performing a neurological exam and EEG at 1 month of age, especially if the exam is favorable.<sup><xref ref-type="bibr" rid="bibr5-0009922811419496">5</xref></sup></p>
<p>Phenobarbital (PHB) is the most widely used antiseizure medication in this age group though it has limited efficacy.<sup><xref ref-type="bibr" rid="bibr51-0009922811419496">51</xref></sup> In fact, both PHB and phenytoin achieve seizure control in less than 50% of cases when used in monotherapy. Levetiracetam has been noted in recent studies to be efficacious in this situation.<sup><xref ref-type="bibr" rid="bibr52-0009922811419496">52</xref></sup> Note must be made of the fact that both PHB and phenytoin have the potential to cause neuronal apoptosis in animal models, and therefore, the pros and cons must be weighed before use in newborns.</p>
<p>In the presence of hypocalcemia, 5% calcium gluconate is given in doses of 200 mg/kg of body weight. Hypomagnesemia warrants treatment with 0.2 mL/kg intramuscularly of a 50% solution.</p>
<p>Vitamin-responsive seizures constitute a subgroup peculiar to the neonatal period. A therapeutic trial of 50 to 100 mg (maximum of 500 mg) of intravenous pyridoxine should be considered in newborns who have been proven to be refractory to first-line agents. In infants with pyridoxine-dependent seizures, a daily oral dose of vitamin B<sub>6</sub> of 50 to 200 mg is recommended with treatment to continue throughout their life in doses not to exceed 15 to 18 mg/kg/d.<sup><xref ref-type="bibr" rid="bibr53-0009922811419496">53</xref></sup> Folinic acid is replaced at 3 to 5 mg/kg/d and pyridoxal phosphate at 30 to 50 mg/kg/d, for life, for folinic acid deficiency and pyridoxal phosphate dependency, respectively.<sup><xref ref-type="bibr" rid="bibr29-0009922811419496">29</xref></sup></p>
<p>For management of seizures in the acute setting please see <xref ref-type="fig" rid="fig7-0009922811419496">Fig 7</xref>. <xref ref-type="table" rid="table2-0009922811419496">Table 2</xref> provides a brief overview of seizure medications for chronic therapy.</p>
<fig id="fig7-0009922811419496" position="float">
<label>Figure 7.</label>
<caption>
<p>Proposed Algorithm for approach to Neonatal Seizures in the Acute care setting</p>
</caption>
<graphic xlink:href="10.1177_0009922811419496-fig7.tif"/>
</fig>
<table-wrap id="table2-0009922811419496" position="float">
<label>Table 2.</label>
<caption>
<p>Drugs used in Neonatal Seizures for Maintenance Therapy</p>
</caption>
<graphic alternate-form-of="table2-0009922811419496" xlink:href="10.1177_0009922811419496-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th align="left">Drug</th>
<th align="center">Commonly used doses</th>
<th align="center">Comments</th>
</tr>
</thead>
<tbody>
<tr>
<td>Phenobarbital</td>
<td>Phenobarbital 5-6 mg/kg/day</td>
<td>Causes drowsiness, irritability</td>
</tr>
<tr>
<td>Phenytoin</td>
<td>3-5 mg/kg/day</td>
<td>Does not follow linear kinetics, drug levels must be carefully monitored</td>
</tr>
<tr>
<td>Levetiracetam</td>
<td>10 mg/kg/day to 40 mg/kg/day</td>
<td>No rigorous studies on efficacy, pharmacokinetics and long term side effect profile, not FDA approved in this age group</td>
</tr>
<tr>
<td>Topiramate</td>
<td>3 mg/kg/day to 10 mg/kg/day</td>
<td>Anecdotal reports regarding efficacy and tolerability, not FDA approved in this age group</td>
</tr>
<tr>
<td>Valproic acid</td>
<td>10 mg/kg/day to 40 mg/kg/day</td>
<td>Increased risk of hepatotoxicity in this age group</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="section25-0009922811419496">
<title>What Is New in Neonatal Seizures?</title>
<p>Amplitude-integrated EEG (aEEG) may offer an alternative to conventional continuous EEG monitoring. The latter can be labor intensive and limited in availability. aEEG uses limited channels as opposed to 16 or more in conventional EEG but runs continuously at the bedside offering real-time information to the neonatologist and nurses. A recent study indicates that the combination of aEEG and neurological exam has the advantage of identifying high-risk neonates.<sup><xref ref-type="bibr" rid="bibr54-0009922811419496">54</xref></sup></p>
<p>Bumetanide, a diuretic with a novel mechanism of action on the Na-K-2Cl contransporter (NKCC1) receptor, is being investigated as an option for adjuvant therapy, with clinical trials awaited at the present time.<sup><xref ref-type="bibr" rid="bibr55-0009922811419496">55</xref></sup> In the neonatal period, GABA functions as an excitatory neurotransmitter. Bumetanide, in animal models, works by suppressing the depolarizing action of GABA.</p>
<p>In conclusion, neonatal seizures can be subtle and hence may pass unnoticed unless the treating physician has a high index of suspicion. Generalized tonic–clonic seizures as seen in older children are a rarity in the age group. In the appropriate setting, the treating physician may consider continuous EEG monitoring to identify seizures, while keeping in mind that electroclinical dissociation is fairly common. Imaging and laboratory investigations may be guided by the clinical presentation and physical examination. Treatment options remain suboptimal; hence, early consideration must be given to a treatable cause such as vitamin-responsive seizure disorder.</p>
</sec>
<sec id="section26-0009922811419496">
<title>Role of the Child Neurologist in Neonatal Seizures</title>
<p>The pediatrician or neonatologist may consider consulting a neurologist for assistance with diagnostic workup, interpretation of long term EEG data, treatment options in the acute setting especially when 1st and 2nd line medications have proven ineffective and counseling families regarding prognosis. Follow up in a multidisciplinary clinic where developmental outcomes can be assessed by pediatricians, neurologists and behavioral specialists may be advantageous to these children. As can be surmised from the above discussion, much work needs to be done in terms of clinical scientific studies, especially in the realm of drug treatment for neonatal seizures. Utilizing such an inter-disciplinary approach can be very beneficial not only to the family but to the medical community as well.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict">
<p>The author declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure">
<p>The author received no financial support for the research, authorship, and/or publication of this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0009922811419496">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lanska</surname><given-names>MJ</given-names></name>
<name><surname>Lanska</surname><given-names>DJ</given-names></name>
<name><surname>Baumann</surname><given-names>RJ</given-names></name>
<name><surname>Kryscio</surname><given-names>RJ</given-names></name>
</person-group>. <article-title>A population based study of neonatal seizures in Fayette County, Kentucky</article-title>. <source>Neurology</source>. <year>1995</year>;<volume>45</volume>:<fpage>724</fpage>-<lpage>732</lpage>.</citation>
</ref>
<ref id="bibr2-0009922811419496">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ronen</surname><given-names>GM</given-names></name>
<name><surname>Penney</surname><given-names>S</given-names></name>
<name><surname>Andrews</surname><given-names>W</given-names></name>
</person-group>. <article-title>The epidemiology of clinical neonatal seizures in Newfoundland: a population-based study</article-title>. <source>J Pediatr</source>. <year>1999</year>;<volume>134</volume>:<fpage>71</fpage>-<lpage>75</lpage>.</citation>
</ref>
<ref id="bibr3-0009922811419496">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Scher</surname><given-names>MS</given-names></name>
<name><surname>Aso</surname><given-names>K</given-names></name>
<name><surname>Beggarly</surname><given-names>ME</given-names></name>
<name><surname>Hamid</surname><given-names>MY</given-names></name>
<name><surname>Steppe</surname><given-names>DA</given-names></name>
<name><surname>Painter</surname><given-names>MJ</given-names></name>
</person-group>. <article-title>Electrographic seizures in preterm and full-term neonates: clinical correlates, associated brain lesions, and risk for neurologic sequelae</article-title>. <source>Pediatrics</source>. <year>1993</year>;<volume>91</volume>:<fpage>128</fpage>-<lpage>134</lpage>.</citation>
</ref>
<ref id="bibr4-0009922811419496">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>du Plessis</surname><given-names>AJ</given-names></name>
<name><surname>Kaufmann</surname><given-names>WE</given-names></name>
<name><surname>Kupsky</surname><given-names>WJ</given-names></name>
</person-group>. <article-title>Intrauterine onset myoclonic encephalopathy associated with cerebral cortical dsysgenesis</article-title>. <source>J Child Neurol</source>. <year>1993</year>;<volume>8</volume>:<fpage>164</fpage>-<lpage>170</lpage>.</citation>
</ref>
<ref id="bibr5-0009922811419496">
<label>5.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Volpe</surname><given-names>JJ</given-names></name>
</person-group>. <article-title>Neonatal seizures</article-title>. In: <person-group person-group-type="editor">
<name><surname>Volpe</surname><given-names>JJ</given-names></name>
</person-group>, ed. <source>Neurology of the Newborn</source>. <publisher-loc>Philadelphia, PA</publisher-loc>: <publisher-name>Saunders Elsevier</publisher-name>; <year>2008</year>:<fpage>203</fpage>-<lpage>244</lpage>.</citation>
</ref>
<ref id="bibr6-0009922811419496">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fenichel</surname><given-names>GM</given-names></name>
<name><surname>Olson</surname><given-names>BJ</given-names></name>
<name><surname>Fitzpatrick</surname><given-names>JE</given-names></name>
</person-group>. <article-title>Heart rate changes in convulsive and non convulsive neonatal apnea</article-title>. <source>Ann Neurol</source>. <year>1980</year>;<volume>7</volume>:<fpage>577</fpage>-<lpage>582</lpage>.</citation>
</ref>
<ref id="bibr7-0009922811419496">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Looney</surname><given-names>CB</given-names></name>
<name><surname>Smith</surname><given-names>JK</given-names></name>
<name><surname>Merck</surname><given-names>LH</given-names></name>
<etal/>
</person-group>. <article-title>Intracranial hemorrhage in asymptomatic neonates: prevalence on MR images and relationship to obstetric and neonatal factors</article-title>. <source>Radiology</source>. <year>2007</year>;<volume>242</volume>:<fpage>535</fpage>-<lpage>541</lpage>.</citation>
</ref>
<ref id="bibr8-0009922811419496">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Twomey</surname><given-names>E</given-names></name>
<name><surname>Twomey</surname><given-names>A</given-names></name>
<name><surname>Ryan</surname><given-names>S</given-names></name>
<name><surname>Murphy</surname><given-names>J</given-names></name>
<name><surname>Donoghue</surname><given-names>VB</given-names></name>
</person-group>. <article-title>MR imaging of term infants with hypoxic-ischaemic encephalopathy as a predictor of neurodevelopmental outcome and late MRI appearances</article-title>. <source>Pediatr Radiol</source>. <year>2010</year>;<volume>40</volume>:<fpage>1526</fpage>-<lpage>1535</lpage>.</citation>
</ref>
<ref id="bibr9-0009922811419496">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Soares-Fernandes</surname><given-names>JP</given-names></name>
<name><surname>Teixeira-Gomes</surname><given-names>R</given-names></name>
<name><surname>Cruz</surname><given-names>R</given-names></name>
<etal/>
</person-group>. <article-title>Neonatal pyruvate dehydrogenase deficiency due to R302H mutation in the PDHA1 gene: MRI findings</article-title>. <source>Pediatr Radiol</source>. <year>2008</year>;<volume>38</volume>:<fpage>559</fpage>-<lpage>562</lpage>.</citation>
</ref>
<ref id="bibr10-0009922811419496">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yamamoto</surname><given-names>H</given-names></name>
<name><surname>Okumura</surname><given-names>A</given-names></name>
<name><surname>Fukuda</surname><given-names>M</given-names></name>
</person-group>. <article-title>Epilepsies and epilepsy syndromes starting in the neonatal period</article-title>. <source>Brain Dev</source>. <year>2011</year>;<volume>33</volume>:<fpage>213</fpage>-<lpage>220</lpage>.</citation>
</ref>
<ref id="bibr11-0009922811419496">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ryan</surname><given-names>SG</given-names></name>
<name><surname>Wiznitzer</surname><given-names>M</given-names></name>
<name><surname>Hollman</surname><given-names>C</given-names></name>
<name><surname>Torres</surname><given-names>MC</given-names></name>
<name><surname>Szekeresova</surname><given-names>M</given-names></name>
<name><surname>Schneider</surname><given-names>S</given-names></name>
</person-group>. <article-title>Benign familial neonatal convulsions: evidence for clinical and genetic heterogeneity</article-title>. <source>Ann Neurol</source>. <year>1991</year>;<volume>29</volume>:<fpage>469</fpage>-<lpage>473</lpage>.</citation>
</ref>
<ref id="bibr12-0009922811419496">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Steinlein</surname><given-names>O</given-names></name>
<name><surname>Schuster</surname><given-names>V</given-names></name>
<name><surname>Fischer</surname><given-names>C</given-names></name>
<name><surname>Haussler</surname><given-names>M</given-names></name>
</person-group>. <article-title>Benign familial neonatal convulsions: confirmation of genetic heterogeneity and further evidence for a second locus on chromosome 8q</article-title>. <source>Hum Genet</source>. <year>1995</year>;<volume>95</volume>:<fpage>411</fpage>-<lpage>415</lpage>.</citation>
</ref>
<ref id="bibr13-0009922811419496">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Miles</surname><given-names>DK</given-names></name>
<name><surname>Holmes</surname><given-names>GL</given-names></name>
</person-group>. <article-title>Benign neonatal seizures</article-title>. <source>J Clin Neurophysiol</source>. <year>1990</year>;<volume>7</volume>:<fpage>369</fpage>-<lpage>379</lpage>.</citation>
</ref>
<ref id="bibr14-0009922811419496">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ohtahara</surname><given-names>S</given-names></name>
<name><surname>Ishida</surname><given-names>T</given-names></name>
<name><surname>Oka</surname><given-names>E</given-names></name>
<etal/>
</person-group>. <article-title>On the specific age-dependent epilepsy syndromes: the early infantile epileptic encephalopathy with suppression burst</article-title>. <source>No to Hattatsu</source>. <year>1976</year>;<volume>8</volume>:<fpage>270</fpage>-<lpage>280</lpage>.</citation>
</ref>
<ref id="bibr15-0009922811419496">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Aicardi</surname><given-names>J</given-names></name>
<name><surname>Goutieres</surname><given-names>F</given-names></name>
</person-group>. <article-title>Encephalopathie myoclonique neonatal</article-title>. <source>Rev Electroencephalogr Neurophysiol Clin</source>. <year>1978</year>;<volume>8</volume>:<fpage>99</fpage>-<lpage>101</lpage>.</citation>
</ref>
<ref id="bibr16-0009922811419496">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lombroso</surname><given-names>CT</given-names></name>
</person-group>. <article-title>Prognosis in neonatal seizures</article-title>. <source>Adv Neurol</source>. <year>1983</year>;<volume>34</volume>:<fpage>101</fpage>-<lpage>113</lpage>.</citation>
</ref>
<ref id="bibr17-0009922811419496">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mizrahi</surname><given-names>EM</given-names></name>
<name><surname>Kellaway</surname><given-names>P</given-names></name>
</person-group>. <article-title>Characterization and classification of neonatal seizures</article-title>. <source>Neurology</source>. <year>1987</year>;<volume>12</volume>:<fpage>1837</fpage>-<lpage>1844</lpage>.</citation>
</ref>
<ref id="bibr18-0009922811419496">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Perlman</surname><given-names>JM</given-names></name>
</person-group>. <article-title>Brain injury in the term infant</article-title>. <source>Semin Perinatol</source>. <year>2004</year>;<volume>28</volume>:<fpage>415</fpage>-<lpage>424</lpage>.</citation>
</ref>
<ref id="bibr19-0009922811419496">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Morgan</surname><given-names>MA</given-names></name>
<name><surname>Hankins</surname><given-names>GD</given-names></name>
<name><surname>Zinberg</surname><given-names>S</given-names></name>
<name><surname>Schulkin</surname><given-names>J</given-names></name>
</person-group>. <article-title>Neonatal encephalopathy and cerebral palsy revisited: the current state of knowledge and the impact of American College of Obstetricians and Gynecologists Task Force report</article-title>. <source>J Perinatol</source>. <year>2005</year>;<volume>25</volume>:<fpage>519</fpage>-<lpage>525</lpage>.</citation>
</ref>
<ref id="bibr20-0009922811419496">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>De Reuck</surname><given-names>JL</given-names></name>
</person-group>. <article-title>Cerebral angioarchitecture and perinatal brain lesions in premature and full term infants</article-title>. <source>Acta Neurol Scand</source>. <year>1984</year>;<volume>70</volume>:<fpage>391</fpage>-<lpage>395</lpage>.</citation>
</ref>
<ref id="bibr21-0009922811419496">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wilson-Costello</surname><given-names>D</given-names></name>
<name><surname>Friedman</surname><given-names>H</given-names></name>
<name><surname>Minich</surname><given-names>N</given-names></name>
<name><surname>Fanaroff</surname><given-names>AA</given-names></name>
<name><surname>Hack</surname><given-names>M</given-names></name>
</person-group>. <article-title>Improved survival rates with increased neurodevelopmental disability for extremely low birth weight infants in the 1990s</article-title>. <source>Pediatrics</source>. <year>2005</year>;<volume>115</volume>:<fpage>997</fpage>-<lpage>1003</lpage>.</citation>
</ref>
<ref id="bibr22-0009922811419496">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Larroque</surname><given-names>B</given-names></name>
<name><surname>Marret</surname><given-names>S</given-names></name>
<name><surname>Ancel</surname><given-names>PY</given-names></name>
<etal/>
</person-group>. <article-title>White matter damage and intraventricular hemorrhage in very preterm infants: the EPIPAGE study</article-title>. <source>J Pediatr</source>. <year>2003</year>;<volume>143</volume>:<fpage>477</fpage>-<lpage>483</lpage>.</citation>
</ref>
<ref id="bibr23-0009922811419496">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Brown</surname><given-names>ZA</given-names></name>
<name><surname>Wald</surname><given-names>A</given-names></name>
<name><surname>Morrow</surname><given-names>RA</given-names></name>
<name><surname>Selke</surname><given-names>S</given-names></name>
<name><surname>Zeh</surname><given-names>J</given-names></name>
<name><surname>Corey</surname><given-names>L</given-names></name>
</person-group>. <article-title>Effect of serological status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant</article-title>. <source>JAMA</source>. <year>2003</year>;<volume>289</volume>:<fpage>203</fpage>-<lpage>209</lpage>.</citation>
</ref>
<ref id="bibr24-0009922811419496">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kimberlin</surname><given-names>DW</given-names></name>
<name><surname>Lin</surname><given-names>CY</given-names></name>
<name><surname>Jacobs</surname><given-names>RF</given-names></name>
<etal/>
</person-group>. <article-title>Natural history of neonatal herpes simplex virus infections in the acyclovir era</article-title>. <source>Pediatrics</source>. <year>2001</year>;<volume>108</volume>:<fpage>223</fpage>-<lpage>229</lpage>.</citation>
</ref>
<ref id="bibr25-0009922811419496">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Garabedian</surname><given-names>M</given-names></name>
</person-group>. <article-title>Hypocalcemia and chromosome 22q11 microdeletion</article-title>. <source>Genet Couns</source>. <year>1999</year>;<volume>10</volume>:<fpage>389</fpage>-<lpage>394</lpage>.</citation>
</ref>
<ref id="bibr26-0009922811419496">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Leary</surname><given-names>LD</given-names></name>
<name><surname>Wang</surname><given-names>D</given-names></name>
<name><surname>Nordli</surname><given-names>DR</given-names><suffix>Jr</suffix></name>
<name><surname>Engelstad</surname><given-names>K</given-names></name>
<name><surname>De Vivo</surname><given-names>DC</given-names></name>
</person-group>. <article-title>Seizure characterization and electroencephalographic features in Glut-1 deficiency syndrome</article-title>. <source>Epilepsia</source>. <year>2003</year>;<volume>44</volume>:<fpage>701</fpage>-<lpage>707</lpage>.</citation>
</ref>
<ref id="bibr27-0009922811419496">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mills</surname><given-names>PB</given-names></name>
<name><surname>Struys</surname><given-names>E</given-names></name>
<name><surname>Jakobs</surname><given-names>C</given-names></name>
<etal/>
</person-group>. <article-title>Mutations in antiquitin in individuals with pyridoxine-dependent seizures</article-title>. <source>Nat Med</source>. <year>2006</year>;<volume>12</volume>:<fpage>307</fpage>-<lpage>309</lpage>.</citation>
</ref>
<ref id="bibr28-0009922811419496">
<label>28.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hyland</surname><given-names>K</given-names></name>
<name><surname>Buist</surname><given-names>NR</given-names></name>
<name><surname>Powell</surname><given-names>BR</given-names></name>
<etal/>
</person-group>. <article-title>Folinic acid responsive seizures: a new syndrome?</article-title> <source>J Inherit Metab Dis</source>. <year>1995</year>;<volume>18</volume>:<fpage>177</fpage>-<lpage>181</lpage>.</citation>
</ref>
<ref id="bibr29-0009922811419496">
<label>29.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gospe</surname><given-names>SM</given-names></name>
</person-group>. <article-title>Neonatal vitamin-responsive epileptic encephalopathies</article-title>. <source>Chang Gung Med J</source>. <year>2010</year>;<volume>33</volume>:<fpage>1</fpage>-<lpage>12</lpage>.</citation>
</ref>
<ref id="bibr30-0009922811419496">
<label>30.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Raju</surname><given-names>TN</given-names></name>
<name><surname>Nelson</surname><given-names>KB</given-names></name>
<name><surname>Ferriero</surname><given-names>D</given-names></name>
<name><surname>Lynch</surname><given-names>JK</given-names></name>
</person-group>. <article-title>Ischemic perinatal stroke: summary of a workshop sponsored by the National Institute of Child Health and Human Development and the National Institute of Neurological Disorders and Stroke</article-title>. <source>Pediatrics</source>. <year>2007</year>;<volume>120</volume>:<fpage>609</fpage>-<lpage>616</lpage>.</citation>
</ref>
<ref id="bibr31-0009922811419496">
<label>31.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Benders</surname><given-names>MJ</given-names></name>
<name><surname>Groenendaal</surname><given-names>F</given-names></name>
<name><surname>Uiterwaal</surname><given-names>CS</given-names></name>
<name><surname>de Vries</surname><given-names>LS</given-names></name>
</person-group>. <article-title>Perinatal arterial stroke in the preterm infant</article-title>. <source>Semin Perinatol</source>. <year>2008</year>;<volume>32</volume>:<fpage>344</fpage>-<lpage>349</lpage>.</citation>
</ref>
<ref id="bibr32-0009922811419496">
<label>32.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wasai</surname><given-names>M</given-names></name>
<name><surname>Dai</surname><given-names>Al</given-names></name>
<name><surname>Ansari</surname><given-names>M</given-names></name>
<etal/>
</person-group>. <article-title>Cerebral venous sinus thrombosis in children: a multicenter cohort from the United States</article-title>. <source>J Child Neurol</source>. <year>2008</year>;<volume>23</volume>:<fpage>26</fpage>-<lpage>31</lpage>.</citation>
</ref>
<ref id="bibr33-0009922811419496">
<label>33.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sanz</surname><given-names>EJ</given-names></name>
<name><surname>De-las-Cuevas</surname><given-names>C</given-names></name>
<name><surname>Kiuru</surname><given-names>A</given-names></name>
<name><surname>Bate</surname><given-names>A</given-names></name>
<name><surname>Edwards</surname><given-names>R</given-names></name>
</person-group>. <article-title>Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis</article-title>. <source>Lancet</source>. <year>2005</year>;<volume>365</volume>:<fpage>482</fpage>-<lpage>487</lpage>.</citation>
</ref>
<ref id="bibr34-0009922811419496">
<label>34.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bandstra</surname><given-names>ES</given-names></name>
<name><surname>Morrow</surname><given-names>CE</given-names></name>
<name><surname>Mansoor</surname><given-names>E</given-names></name>
<name><surname>Accornero</surname><given-names>VH</given-names></name>
</person-group>. <article-title>Prenatal drug exposure: infant and toddler outcomes</article-title>. <source>J Addict Dis</source>. <year>2010</year>;<volume>29</volume>:<fpage>245</fpage>-<lpage>258</lpage>.</citation>
</ref>
<ref id="bibr35-0009922811419496">
<label>35.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Miller</surname><given-names>SP</given-names></name>
<name><surname>Tasch</surname><given-names>T</given-names></name>
<name><surname>Sylvain</surname><given-names>M</given-names></name>
<name><surname>Farmer</surname><given-names>JP</given-names></name>
<name><surname>O’Gorman</surname><given-names>AM</given-names></name>
<name><surname>Shevell</surname><given-names>MI</given-names></name>
</person-group>. <article-title>Tuberous sclerosis complex and neonatal seizures</article-title>. <source>J Child Neurol</source>. <year>1998</year>;<volume>13</volume>:<fpage>619</fpage>-<lpage>623</lpage>.</citation>
</ref>
<ref id="bibr36-0009922811419496">
<label>36.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sujansky</surname><given-names>E</given-names></name>
<name><surname>Conradi</surname><given-names>S</given-names></name>
</person-group>. <article-title>Sturge-Weber syndrome: age of onset of seizures and glaucoma and the prognosis for affected children</article-title>. <source>J Child Neurol</source>. <year>1995</year>;<volume>10</volume>:<fpage>49</fpage>-<lpage>58</lpage>.</citation>
</ref>
<ref id="bibr37-0009922811419496">
<label>37.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Saliba</surname><given-names>RM</given-names></name>
<name><surname>Annegers</surname><given-names>FJ</given-names></name>
<name><surname>Waller</surname><given-names>DK</given-names></name>
<name><surname>Tyson</surname><given-names>JE</given-names></name>
<name><surname>Mizrahi</surname><given-names>EM</given-names></name>
</person-group>. <article-title>Risk factors for neonatal seizures: a population based study, Harris County, Texas, 1992-1994</article-title>. <source>Am J Epidemiol</source>. <year>2001</year>;<volume>154</volume>:<fpage>14</fpage>-<lpage>20</lpage>.</citation>
</ref>
<ref id="bibr38-0009922811419496">
<label>38.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lanska</surname><given-names>MJ</given-names></name>
<name><surname>Lanska</surname><given-names>DJ</given-names></name>
<name><surname>Baumann</surname><given-names>RJ</given-names></name>
<name><surname>Kryscio</surname><given-names>RJ</given-names></name>
</person-group>. <article-title>A population based study of neonatal seizures in Fayette County, Kentucky</article-title>. <source>Neurology</source>. <year>1995</year>;<volume>45</volume>:<fpage>724</fpage>-<lpage>732</lpage>.</citation>
</ref>
<ref id="bibr39-0009922811419496">
<label>39.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pisani</surname><given-names>F</given-names></name>
<name><surname>Barilli</surname><given-names>AL</given-names></name>
<name><surname>Sisti</surname><given-names>L</given-names></name>
<name><surname>Bevilacqua</surname><given-names>G</given-names></name>
<name><surname>Seri</surname><given-names>S</given-names></name>
</person-group>. <article-title>Preterm infants with video-EEG confirmed neonatal seizures: outcome at 30 months of age</article-title>. <source>Brain Dev</source>. <year>2008</year>;<volume>30</volume>:<fpage>20</fpage>-<lpage>30</lpage>.</citation>
</ref>
<ref id="bibr40-0009922811419496">
<label>40.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Clancy</surname><given-names>RR</given-names></name>
<name><surname>Legido</surname><given-names>A</given-names></name>
<name><surname>Lewis</surname><given-names>D</given-names></name>
</person-group>. <article-title>Occult neonatal seizures</article-title>. <source>Epilepsia</source>. <year>1988</year>;<volume>29</volume>:<fpage>256</fpage>-<lpage>261</lpage>.</citation>
</ref>
<ref id="bibr41-0009922811419496">
<label>41.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Weiner</surname><given-names>SP</given-names></name>
<name><surname>Painter</surname><given-names>MJ</given-names></name>
<name><surname>Geva</surname><given-names>D</given-names></name>
<name><surname>Guthrie</surname><given-names>RD</given-names></name>
<name><surname>Scher</surname><given-names>MS</given-names></name>
</person-group>. <article-title>Neonatal seizures: electroclinical dissociation</article-title>. <source>Pediatr Neurol</source>. <year>1991</year>;<volume>7</volume>:<fpage>363</fpage>-<lpage>368</lpage>.</citation>
</ref>
<ref id="bibr42-0009922811419496">
<label>42.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mizrahi</surname><given-names>EM</given-names></name>
<name><surname>Kellaway</surname><given-names>P</given-names></name>
</person-group>. <article-title>Characterization and classification of neonatal seizures</article-title>. <source>Neurology</source>. <year>1987</year>;<volume>37</volume>:<fpage>1837</fpage>-<lpage>1844</lpage>.</citation>
</ref>
<ref id="bibr43-0009922811419496">
<label>43.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Toet</surname><given-names>MC</given-names></name>
<name><surname>Hellström-Westas</surname><given-names>L</given-names></name>
<name><surname>Groenendaal</surname><given-names>F</given-names></name>
<name><surname>Eken</surname><given-names>P</given-names></name>
<name><surname>de Vries</surname><given-names>LS</given-names></name>
</person-group>. <article-title>Amplitude integrated EEG 3 and 6 hours after birth in full term neonates with hypoxic-ischaemic encephalopathy</article-title>. <source>Arch Dis Child Fetal Neonatal Ed</source>. <year>1999</year>;<volume>81</volume>:<fpage>F19</fpage>-<lpage>F23</lpage>.</citation>
</ref>
<ref id="bibr44-0009922811419496">
<label>44.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ronen</surname><given-names>GM</given-names></name>
<name><surname>Buckley</surname><given-names>D</given-names></name>
<name><surname>Penney</surname><given-names>S</given-names></name>
<name><surname>Streiner</surname><given-names>DL</given-names></name>
</person-group>. <article-title>Long term prognosis in children with neonatal seizures: a population based study</article-title>. <source>Neurology</source>. <year>2007</year>;<volume>69</volume>:<fpage>1816</fpage>-<lpage>1822</lpage>.</citation>
</ref>
<ref id="bibr45-0009922811419496">
<label>45.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Scher</surname><given-names>MS</given-names></name>
<name><surname>Aso</surname><given-names>K</given-names></name>
<name><surname>Beggarly</surname><given-names>ME</given-names></name>
<name><surname>Hamid</surname><given-names>MY</given-names></name>
<name><surname>Steppe</surname><given-names>DA</given-names></name>
<name><surname>Painter</surname><given-names>MJ</given-names></name>
</person-group>. <article-title>Electrographic seizures in preterm and full-term neonates: clinical correlates, associated brain lesions, and risk for neurologic sequelae</article-title>. <source>Pediatrics</source>. <year>1993</year>;<volume>91</volume>:<fpage>128</fpage>-<lpage>134</lpage>.</citation>
</ref>
<ref id="bibr46-0009922811419496">
<label>46.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Younkin</surname><given-names>DP</given-names></name>
<name><surname>Delivoria-Papadopoulos</surname><given-names>M</given-names></name>
<name><surname>Maris</surname><given-names>J</given-names></name>
<name><surname>Donlon</surname><given-names>E</given-names></name>
<name><surname>Clancy</surname><given-names>CR</given-names></name>
<name><surname>Chance</surname><given-names>B</given-names></name>
</person-group>. <article-title>Cerebral metabolic effects of neonatal seizures measured with in vivo 31P NMR spectroscopy</article-title>. <source>Ann Neurol</source>. <year>1986</year>;<volume>20</volume>:<fpage>513</fpage>-<lpage>519</lpage>.</citation>
</ref>
<ref id="bibr47-0009922811419496">
<label>47.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tekgul</surname><given-names>H</given-names></name>
<name><surname>Gauvreau</surname><given-names>K</given-names></name>
<name><surname>Soul</surname><given-names>J</given-names></name>
<etal/>
</person-group>. <article-title>The current etiological profile and neurodevelopmental outcome of seizures in term newborn infants</article-title>. <source>Pediatrics</source>. <year>2006</year>;<volume>117</volume>:<fpage>1270</fpage>-<lpage>1280</lpage>.</citation>
</ref>
<ref id="bibr48-0009922811419496">
<label>48.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Garfinkle</surname><given-names>J</given-names></name>
<name><surname>Shevell</surname><given-names>MI</given-names></name>
</person-group>. <article-title>Prognostic factors and development of a scoring system for outcome of neonatal seizures in term infants</article-title>. <source>Eur J Paediatr Neurol</source>. <year>2011</year>;<volume>15</volume>:<fpage>222</fpage>-<lpage>229</lpage>.</citation>
</ref>
<ref id="bibr49-0009922811419496">
<label>49.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Parker</surname><given-names>S</given-names></name>
<name><surname>Zuckerman</surname><given-names>B</given-names></name>
<name><surname>Bauchner</surname><given-names>H</given-names></name>
<name><surname>Frank</surname><given-names>D</given-names></name>
<name><surname>Vinci</surname><given-names>R</given-names></name>
<name><surname>Cabral</surname><given-names>H</given-names></name>
</person-group>. <article-title>Jitteriness in full term neonates: prevalence and correlates</article-title>. <source>Pediatrics</source>. <year>1990</year>;<volume>85</volume>:<fpage>17</fpage>-<lpage>23</lpage>.</citation>
</ref>
<ref id="bibr50-0009922811419496">
<label>50.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Maurer</surname><given-names>VO</given-names></name>
<name><surname>Ritzi</surname><given-names>M</given-names></name>
<name><surname>Bianchetti</surname><given-names>MG</given-names></name>
<name><surname>Ramelli</surname><given-names>GP</given-names></name>
</person-group>. <article-title>Benign neonatal sleep myoclonus: a review of the literature</article-title>. <source>Pediatrics</source>. <year>2010</year>;<volume>125</volume>:<fpage>e919</fpage>-<lpage>e924</lpage>.</citation>
</ref>
<ref id="bibr51-0009922811419496">
<label>51.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sankar</surname><given-names>R</given-names></name>
<name><surname>Painter</surname><given-names>MJ</given-names></name>
</person-group>. <article-title>Neonatal seizures: after all these years we still love what doesn’t work</article-title>. <source>Neurology</source>. <year>2005</year>;<volume>64</volume>:<fpage>776</fpage>-<lpage>777</lpage>.</citation>
</ref>
<ref id="bibr52-0009922811419496">
<label>52.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Boylan</surname><given-names>GB</given-names></name>
<name><surname>Rennie</surname><given-names>JM</given-names></name>
<name><surname>Chorley</surname><given-names>G</given-names></name>
<etal/>
</person-group>. <article-title>Second-line anticonvulsant treatment of neonatal seizures: a video-EEG monitoring study</article-title>. <source>Neurology</source>. <year>2004</year>;<volume>62</volume>:<fpage>486</fpage>-<lpage>488</lpage>.</citation>
</ref>
<ref id="bibr53-0009922811419496">
<label>53.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Baxter</surname><given-names>P</given-names></name>
</person-group>. <article-title>Pyridoxine dependent and pyridoxine responsive seizures</article-title>. In: <person-group person-group-type="editor">
<name><surname>Baxter</surname><given-names>P</given-names></name>
</person-group>, ed. <source>Vitamin Responsive Conditions in Paediatric Neurology</source>. <publisher-loc>London, England</publisher-loc>: <publisher-name>MacKeith Press</publisher-name>; <year>2001</year>:<fpage>109</fpage>-<lpage>165</lpage>.</citation>
</ref>
<ref id="bibr54-0009922811419496">
<label>54.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Shalak</surname><given-names>LF</given-names></name>
<name><surname>Laptook</surname><given-names>AR</given-names></name>
<name><surname>Velaphi</surname><given-names>SC</given-names></name>
<name><surname>Perlman</surname><given-names>JM</given-names></name>
</person-group>. <article-title>Amplitude-integrated electroencephalography coupled with an early neurological examination enhances prediction of term infants at risk for persistent encephalopathy</article-title>. <source>Pediatrics</source>. <year>2003</year>;<volume>111</volume>:<fpage>351</fpage>-<lpage>357</lpage>.</citation>
</ref>
<ref id="bibr55-0009922811419496">
<label>55.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dzhala</surname><given-names>VI</given-names></name>
<name><surname>Brumback</surname><given-names>AC</given-names></name>
<name><surname>Staley</surname><given-names>KJ</given-names></name>
</person-group>. <article-title>Bumetanide enhances phenobarbital efficacy in a neonatal seizure model</article-title>. <source>Ann Neurol</source>. <year>2008</year>;<volume>63</volume>:<fpage>222</fpage>-<lpage>235</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>